CYD0281, a Bcl-2 BH4 domain antagonist, inhibits tumor angiogenesis and breast cancer tumor growth.
Saved in:
| Title: | CYD0281, a Bcl-2 BH4 domain antagonist, inhibits tumor angiogenesis and breast cancer tumor growth. |
|---|---|
| Authors: | Lin, Yihua1 (AUTHOR), Zhao, Yiling1 (AUTHOR), Chen, Minggui1 (AUTHOR), Li, Zishuo1 (AUTHOR), Liu, Qiao1 (AUTHOR), Chen, Jian1 (AUTHOR), Ding, Yi1 (AUTHOR), Ding, Chunyong2 (AUTHOR), Ding, Ye2 (AUTHOR), Qi, Cuiling1 (AUTHOR), Zheng, Lingyun1 (AUTHOR), Li, Jiangchao1 (AUTHOR), Zhang, Rongxin1 (AUTHOR), Zhou, Jia2 (AUTHOR) jizhou@utmb.edu, Wang, Lijing1 (AUTHOR) wanglijing62@163.com, Zhang, Qian-Qian1 (AUTHOR) vinny223@126.com |
| Source: | BMC Cancer. 5/26/2023, Vol. 23 Issue 1, p1-18. 18p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
